Accueil
Envoyer à un ami
Imprimer
Grand
Petit
Partager
ACTUALITES

Novartis International AG - Novartis announces AMG 334 significantly reduces patients' monthly migraine days in phase II study of chronic migraine prevention


- 8 Juin 2016 modifié le 1 Janvier 1970


Novartis International AG / Novartis announces AMG 334 significantly reduces patients' monthly migraine days in phase II study of chronic migraine prevention . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely...

Source : http://www.romandie.com/news/Novartis-Internationa...


ACTUALITES | INTERNATIONAL | TCHAD | POLITIQUE | CULTURE | EXCLUSIF | Revue de Presse | English News | 中國